True Wealth Design’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Buy
7,785
+165
+2% +$9.47K 0.11% 46
2026
Q1
$462K Buy
7,620
+1,434
+23% +$83.6K 0.13% 36
2025
Q4
$334K Buy
6,186
+5,112
+476% +$246K 0.1% 39
2025
Q3
$48.4K Buy
1,074
+936
+678% +$43.7K 0.01% 318
2025
Q2
$6.37K Sell
138
-1,297
-90% -$63.7K ﹤0.01% 721
2025
Q1
$87.5K Buy
1,435
+117
+9% +$6.82K 0.03% 107
2024
Q4
$74.5K Buy
1,318
+58
+5% +$3.24K 0.03% 100
2024
Q3
$65.2K Buy
1,260
+942
+296% +$44.2K 0.03% 98
2024
Q2
$13.2K Hold
318
﹤0.01% 232
2024
Q1
$17.2K Buy
318
+23
+8% +$1.17K ﹤0.01% 220
2023
Q4
$15.1K Buy
295
+262
+794% +$13.8K ﹤0.01% 218
2023
Q3
$1.92K Hold
33
﹤0.01% 269
2023
Q2
$2.11K Sell
33
-224
-87% -$15K ﹤0.01% 273
2023
Q1
$17.8K Sell
257
-102
-28% -$7.19K 0.01% 206
2022
Q4
$25.8K Buy
+359
New +$27.1K 0.01% 176

Other funds holding BMY

True Wealth Design's BMY Position: Q2 2026 in Review

True Wealth Design increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2026, buying an estimated $9.47K and bringing the position to 7,785 shares worth $449K. The position accounts for 0.11% of the portfolio, ranked #46.

True Wealth Design first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $462K in Q1 2026. 1,011 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • True Wealth Design held 7,785 shares of Bristol-Myers Squibb worth $449K as of Q2 2026.
  • True Wealth Design bought 165 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.47K.
  • Bristol-Myers Squibb made up 0.11% of True Wealth Design's portfolio in Q2 2026, its #46 holding.
  • True Wealth Design first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's Bristol-Myers Squibb position peaked at $462K in Q1 2026.
  • 1,011 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.